These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3843296)

  • 21. [Cytotoxic cells of the NK type - their characteristics and role in anti-neoplastic immunity].
    Janiak M; Lipski S
    Postepy Hig Med Dosw; 1982; 36(1-3):95-131. PubMed ID: 6763997
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability.
    Abo T; Cooper MD; Balch CM
    J Immunol; 1982 Oct; 129(4):1752-7. PubMed ID: 6980948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Natural cellular immunity as the effector mechanism in tumor defense].
    Zielinski C; Müller C
    Acta Med Austriaca; 1987; 14(2):34-6. PubMed ID: 3630578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of long-term human cytolytic cell lines with persistent natural killer activity.
    Krensky AM; Ault KA; Reiss CS; Strominger JL; Burakoff SJ
    J Immunol; 1982 Oct; 129(4):1748-51. PubMed ID: 6286775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [NK cells. II. Their phenotypic and functional heterogeneity].
    Mikołajczyk-Cichońska A; Gościcka T
    Postepy Hig Med Dosw; 2001; 55(6):787-802. PubMed ID: 11875777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of natural killer function through activation of the T11 E rosette receptor.
    Schmidt RE; Michon JM; Woronicz J; Schlossman SF; Reinherz EL; Ritz J
    J Clin Invest; 1987 Jan; 79(1):305-8. PubMed ID: 3098784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Natural killers and macrophages: their activity in leukemias].
    Fi FT
    Eksp Med Morfol; 1985; 24(2):63-70. PubMed ID: 3933945
    [No Abstract]   [Full Text] [Related]  

  • 28. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroendocrine regulation and tumor immunity.
    Toni R; Mirandola P; Gobbi G; Vitale M
    Eur J Histochem; 2007; 51 Suppl 1():133-8. PubMed ID: 17703604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
    Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
    J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of the NKG2D immunoreceptor and its ligands.
    Raulet DH
    Nat Rev Immunol; 2003 Oct; 3(10):781-90. PubMed ID: 14523385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotype of rat natural killer cells defined by monoclonal antibodies marking rat lymphocyte subsets.
    Cantrell DA; Robins RA; Brooks CG; Baldwin RW
    Immunology; 1982 Jan; 45(1):97-103. PubMed ID: 7056570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line.
    Howell DN; Andreotti PE; Dawson JR; Cresswell P
    J Immunol; 1985 Feb; 134(2):971-6. PubMed ID: 3871222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
    Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
    Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
    Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Principles of tumor immunology.
    Den Otter W
    Postepy Hig Med Dosw; 1988; 42(2):117-24. PubMed ID: 3075997
    [No Abstract]   [Full Text] [Related]  

  • 38. Exposing tumor cells to killer cell attack.
    Watzl C; Long EO
    Nat Med; 2000 Aug; 6(8):867-8. PubMed ID: 10932221
    [No Abstract]   [Full Text] [Related]  

  • 39. Mistaken notions about natural killer cells.
    Yokoyama WM
    Nat Immunol; 2008 May; 9(5):481-5. PubMed ID: 18425104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system.
    Zwirner NW; Fuertes MB; Girart MV; Domaica CI; Rossi LE
    Cytokine Growth Factor Rev; 2007; 18(1-2):159-70. PubMed ID: 17324607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.